The charts below are based on available data at the time of publication. Charts may not represent all cases, but only cases where sufficient details are known.
Cases and Deaths
Note: Cases are charted below according to the date COVID-19 symptoms began (when known), not the date they were reported by MSDH. Past dates on this chart are updated as we perform disease investigations.
Cases and Deaths by Age
Full screen: Click or touch a chart to view full-screen.
Cases and Deaths by Race
Full screen: Click or touch a chart to view full-screen.
Cases and Deaths in Pregnant Women
Updated monthly or as needed
Full screen: Click or touch a chart to view full-screen.
Hospitalizations
Hospitalization Trend to Date
Full screen: Click or touch a chart to view full-screen.
Surveillance
Full screen: Click or touch a chart to view full-screen.
Variants by Date
Syndromic Surveillance
Emergency department visits by those with symptoms characteristic of COVID-19, influenza and pneumonia, updated weekly.
Pediatric MIS-C Cases and Deaths
Updated monthly
Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition associated with COVID-19 that causes inflammation in many body parts, including the heart and other vital organs.
Monoclonal Antibody (mAb) Treatment
Monoclonal Antibody Utilization
Monoclonal antibody (mAb) treatment is the leading treatment for mild to moderate COVID-19 illness. Doses can be administered in inpatient or outpatient settings.
Testing for COVID-19
Full screen: Click or touch a chart to view full-screen.
Combined Testing Total
Statewide COVID-19 test total as of June 26, 2022: 6,676,815
Combined testing totals (MSDH, hospital laboratories and commercial testing providers) from 2020 to date
Beginning April 4, 2022, negative test results from facilities with a CLIA certificate of waiver are no longer required to be reported. The totals in each category above reflect only the total tests reported to MSDH.
Vaccination Charts
Vaccination charts can be found with our daily vaccination report.